It seems that 1,25(OH)2D3 preconditioning enhance cediranib efficacy not only through the modulation of VEGFR2 expression, as we documented previously in A375 and SK-MEL-28 melanoma cells [17], but also through the modulation of mitochondrial bioenergetics. This evidence concerns the gene KDR and melanoma.